Basic Information
Personalised Medicine (PM) represents a paradigm shift from a “one size fits all” approach to an optimised strategy for prevention, diagnosis and treatment of disease for each individual person, based on his or her unique characteristics. In this way, PM puts the patient at the very centre of health care, aiming for optimised management of a patient’s disease
and/or the predisposition to disease. Recent developments in areas such as diagnostic tests, medical imaging, biosignal monitoring, omics technologies, molecular pathways,
lifestyle data, real-time monitoring of conditions and information technology, support this development.
|
Network
|
ERA PerMed
|
|
Website
|
http://www.erapermed.eu/joint-transnational-call-2019/
|
|
Aim of the joint call
|
With its second transnational call, ERA PerMed will foster research and innovation activities building close linkages between basic biomedical research, clinical research, bioinformatics, epidemiology, socio-economic research, as well as research on the integration of PM into clinical practice and on ethical, legal and social implications. The overarching goal is to improve disease management, with better patient stratification, diagnostics and treatment protocols, and disease prevention. Proposals submitted under this call are expected to demonstrate the applicability of project outcomes into clinical practice as well as to describe the impact on the health care systems.
|
|
Type of joint call
|
Two Stages
- Call with pre-proposals and full proposals submissions
|
|
Events
|
|
Launch date
|
09/01/2019
|
|
Deadline Pre-Proposal
|
07/03/2019 Submitted proposal: n/a
|
|
Deadline Full-Proposal
|
17/06/2019 Submitted proposal: n/a
|
|
Evaluation End Date
|
n/a
Successful proposal: n/a
Proposals funded: n/a
|
|
|
Is call co-funded?
|
No
|
|
Call follow up funding
|
n/a
|
|
Call reasons
|
n/a
|
|
Research fields
|
|
|
Type of research
|
- Basic research
- Applied Research
|
|
Target groups
|
n/a
|
|
Participating networks
|
n/a
|
